The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
High α‐fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: Significance of hepatitis virus infection, age, p53 and β‐catenin mutations
Open accessAbstract
α‐Fetoprotein (AFP) is often elevated in hepatocellular carcinoma (HCC). This study was to elucidate the significance and related factors of AFP elevation in HCC in 781 unifocal HCCs receiving curative hepatectomy. We showed that high AFP (> 200 ng/ml), which was associated with AFP mRNA expression in HCC (p = 0.00001), correlated with major clinicopathologic factors. Younger age (≤ 55 years; p = 0.00001), hepatitis B surface antigen (HBsAg) in serum (p = 0.00001), p53 mutation (p = 0.008), large tumor (p = 0.00001), vascular invasion (p = 0.00001) and early tumor recurrence (p = 0.00001) were significant associates of high AFP, while anti‐HCV in serum and β‐catenin mutation in HCC had less frequent high AFP (p = 0.013 and < 0.0001, respectively). We also showed that HCC with high AFP had a lower 10‐year survival (p < 0.0001), particularly in large HCC (p < 0.0001). At univariate analysis, high AFP (p < 0.0001), HBsAg positivity (p = 0.05), p53 mutation (p = 0.0004), liver cirrhosis (p = 0.0094), large tumor (p = 0.0003), vascular invasion (p < 0.0001) and early recurrence (p < 0.0001) were significant unfavorable prognostic factors. In Cox proportional hazards regression analysis, high AFP remained a borderline significance (OR = 1.2; CI = 1.0–1.4) after adjustment for the effect of tumor size and tumor stage (p = 0.0821). Furthermore, the detection of AFP mRNA in the liver of AFP mRNA‐positive HCC was associated with more frequent early recurrence (p = 0.0026) and might be a useful marker of intrahepatic spread. We therefore conclude that AFP elevation, more than a coincidental epiphenomenon, appears to contribute to vascular invasion and HCC progression and help to identify subsets of HCC patients with increased risk for early recurrence and poor prognosis after hepatectomy. © 2004 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
‘Touchdown’ PCR to circumvent spurious priming during gene amplification
Don, R. H., Cox, P. T., Wainwright, B. J., Baker, K., & Mattick, J. S. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.14.4008 · Cited by 2,586
Imamura, H., Matsuyama, Y., Tanaka, E., Ohkubo, T., Hasegawa, K., Miyagawa, S., Sugawara, Y., Minagawa, M., Takayama, T., Kawasaki, S., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00360-4 · Cited by 1,589
Alpha-Fetoprotein in Ontogenesis and its Association with Malignant Tumors
(1971) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60523-0 · Cited by 877
Li, Y., Tang, Z.-Y., Ye, S.-L., Liu, Y.-K., Chen, J., Xue, Q., Chen, J., Gao, D.-M., & Bao, W.-H. (2001) · World Journal of Gastroenterology · doi:10.3748/wjg.v7.i5.630 · Cited by 359
Transcriptional control of the murine albumin/alpha-fetoprotein locus during development.
Tilghman, S. M., & Belayew, A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5254 · Cited by 354
Abrogation of p53-Induced Apoptosis by the Hepatitis B Virus X Gene
Wang, X. W. (2003) · Hepatocellular Carcinoma · doi:10.1385/1-59259-079-9:57 · Cited by 321
Nomura, F., Ohnishi, K., & Tanabe, Y. (1989) · Cancer · doi:10.1002/1097-0142(19891015)64:8<1700::aid-cncr2820640824>3.0.co;2-z · Cited by 305
Hsu, H.-C., Jeng, Y.-M., Mao, T.-L., Chu, J.-S., Lai, P.-L., & Peng, S.-Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64590-7 · Cited by 294
Self-citationHuang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
Truant, R., Antunovic, J., Greenblatt, J., Prives, C., & Cromlish, J. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1851-1859.1995 · Cited by 255
Pan, H., Ou, Y., Peng, S., Liu, S., Lai, P., Lee, P., Sheu, J., Chen, C., & Hsu, H. (2003) · Cancer · doi:10.1002/cncr.11487 · Cited by 251
Self-citationTissue‐specific expression of porphobilinogen deaminase: Two isoenzymes from a single gene
GRANDCHAMP, B., DE VERNEUIL, H., BEAUMONT, C., CHRETIEN, S., WALTER, O., & NORDMANN, Y. (1987) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1987.tb10548.x · Cited by 210
Kusano, N., Shiraishi, K., Kubo, K., Oga, A., Okita, K., & Sasaki, K. (1999) · Hepatology · doi:10.1002/hep.510290636 · Cited by 208
Damalas, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4912 · Cited by 207
p53-Mediated Repression of Alpha-Fetoprotein Gene Expression by Specific DNA Binding
Lee, K. C., Crowe, A. J., & Barton, M. C. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1279 · Cited by 175
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Genetic analysis of alpha-fetoprotein synthesis in mice.
Belayew, A., & Tilghman, S. M. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.11.1427 · Cited by 134
Tissue-specific transcription of the mouse alpha-fetoprotein gene promoter is dependent on HNF-1.
Feuerman, M. H., Godbout, R., Ingram, R. S., & Tilghman, S. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.10.4204 · Cited by 126
Hsu, H., Tseng, H.-J., Lai, P., et al. (1993) · PubMed · Cited by 123
Self-citationKoide, N., Nishio, A., Igarashi, J., Kajikawa, S., Adachi, W., & Amano, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00214-2 · Cited by 118
Li, M. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i3.469 · Cited by 113
Biological role of α-fetoprotein in cancer: prospects for anticancer therapy
Mizejewski, G. J. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.6.709 · Cited by 113
Devereux, T. R., Stern, M. C., Flake, G. P., Yu, M. C., Zhang, Z., London, S. J., & Taylor, J. A. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1041 · Cited by 103
Alpha-fetoprotein enhances the proliferation of human hepatoma cells in vitro
Wang, X.-W., & Xie, H. J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00529-3 · Cited by 101
Growth-Regulative Activity of Human Alpha-Fetoprotein for Different Types of Tumor and Normal Cells
Dudich, E. I., Semenkova, L., Gorbatova, E., Dudich, I. V., Khromykh, L. M., Tatulov, E., Grechko, G. K., & Sukhikh, G. T. (1998) · Tumor Biology · doi:10.1159/000029972 · Cited by 80
Ogden, S. K., Lee, K. C., & Barton, M. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004449200 · Cited by 62
Peng, S., Hsu, H., Lai, P., Tsung, P.-T., Chu, J.-S., Lee, P., & Chen, D. (1993) · Hepatology · doi:10.1002/hep.1840170108 · Cited by 61
Self-citationPeng, S., Lai, P. L., Chu, J. S., et al. (1993) · PubMed · Cited by 60
Self-citationp53 Targets Chromatin Structure Alteration to Repress α-Fetoprotein Gene Expression
Ogden, S. K., Lee, K. C., Wernke-Dollries, K., Stratton, S. A., Aronow, B. J., & Barton, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100381200 · Cited by 43
Nishio, H., Heiskanen, M., Palotie, A. V., Bélanger, L., & Dugaiczyk, A. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0306 · Cited by 40
Cited by
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Durnez, A., Verslype, C., Nevens, F., Fevery, J., Aerts, R., Pirenne, J., Lesaffre, E., Libbrecht, L., Desmet, V, & Roskams, T. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02468.x · Cited by 426
β-Catenin signaling in hepatocellular carcinoma
Xu, C., Xu, Z., Zhang, Y., Evert, M., Calvisi, D. F., & Chen, X. (2022) · Journal of Clinical Investigation · doi:10.1172/jci154515 · Cited by 305
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
Sauzay, C., Petit, A., Bourgeois, A.-M., Barbare, J.-C., Chauffert, B., Galmiche, A., & Houessinon, A. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.10.006 · Cited by 291
Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story
Halazun, K. J., Najjar, M., Abdelmessih, R. M., Samstein, B., Griesemer, A. D., Guarrera, J. V., Kato, T., Verna, E. C., Emond, J. C., & Brown, R. S. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001966 · Cited by 281
Metadata
- Authors
- Peng, S., Chen, W. J., Lai, P., Jeng, Y., Sheu, J., & Hsu, H.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2004-06-02
- Volume
- 112
- Issue
- 1
- Pages
- 44-50
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2073329174
- Cited by
- 295
- References
- 30
- FWCI
- 8.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.